This sort of transaction is reasonably common in the biotech space but by God it's expensive money. The financiers usually charge 12% pa minimum plus a facility fee. It's desperation stuff in my view.
- Forums
- ASX - By Stock
- ACR
- Ann: Acrux receives $1.73m advance on FY25 R&D Tax Incentive
ACR
acrux limited
Add to My Watchlist
0.00%
!
1.7¢

Ann: Acrux receives $1.73m advance on FY25 R&D Tax Incentive, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.931M |
Open | High | Low | Value | Volume |
1.6¢ | 1.7¢ | 1.6¢ | $775 | 46.35K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 984509 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 157783 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 984509 | 0.016 |
7 | 1309314 | 0.015 |
3 | 420000 | 0.014 |
2 | 397000 | 0.013 |
1 | 80000 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 157783 | 2 |
0.018 | 252359 | 2 |
0.019 | 677115 | 3 |
0.020 | 50000 | 1 |
0.021 | 203466 | 1 |
Last trade - 11.36am 30/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online